Effect of characteristics of pharmacotherapy on non-adherence in chronic cardiovascular disease: A systematic review and meta-analysis of observational studies.

INTRODUCTION: Cardiovascular medications are effective in prevention of cardiovascular diseases (CVD); however, medication non-adherence contributes to morbidity and mortality. OBJECTIVE: This systematic review and meta-analysis aims to summarise the evidence regarding the relationship between characteristics of drug therapy (pharmacotherapy) and medication non-adherence in the CVD population. METHODS: Systematic searches in PubMed, LILACS, Academic Search and CINAHL databases for observational studies that enrolled adults with CVD were performed, from January 1960 to December 2015. The meta-analysis tested the association between characteristics of pharmacotherapy and self-reported medication non-adherence outcome, using a random effects model. To investigate heterogeneity, we performed subgroup analysis and sensitivity analysis. RESULTS: Twenty-four cross-sectional studies and 7 cohort studies were included in this review. Based on 31 studies including 27 441 participants, we performed meta-analyses for all the characteristics of drug therapy that at least 2 studies evaluated, with a total of fourteen meta-analyses. The pooled results showed that studies which evaluate whether participants have insurance or another program that assists with medication costs, but not full coverage (OR = 0.63; 95% CI: 0.53-0.74; P < .001; I2  = 0%, P = .938), and a dosing frequency of twice or more daily (OR = 1.38; 95% CI: 1.13-1.69; P < .001) were associated with non-adherence. CONCLUSIONS AND RELEVANCE: The results of this review suggest that access to insurance or another program that assists with medication costs was a protection factor for non-adherence. On the other hand, a high frequency of dosing was a risk factor for non-adherence. Therefore, these characteristics of pharmacotherapy must be considered to improve medication adherence among CVD patients.

[HIV and syphilis coinfection in pregnancy and vertical HIV transmission: a study based on epidemiological surveillance data]. / Coinfecção HIV/sífilis na gestação e transmissão vertical do HIV: um estudo a partir de dados da vigilância epidemiológica.

OBJECTIVE: To estimate the rate of HIV and syphilis coinfection among pregnant women living in Porto Alegre, Brazil, as well as the association of coinfection with vertical HIV transmission and socioeconomic variables. METHOD: This analytical retrospective cross-sectional study employed data from the regular epidemiological surveillance system for the period from 2010 to 2013. Data were obtained regarding pregnant women with HIV and exposed children, syphilis in pregnancy, and congenital syphilis. RESULTS: The study population included 1 500 HIV-positive women with deliveries from 2010 to 2013. Of these, 155 (10.3%) were also infected with syphilis, corresponding to an HIV and syphilis coinfection rate of 10.2% (± 1.5%). The coinfected group had lower education levels, higher prevalence of black women, and greater HIV exposure related to drug use by the woman or a partner. Coinfected women had more delayed HIV diagnosis (for example, during childbirth) and greater prevalence of lacking prenatal care (44%). Crude analysis showed an association between vertical HIV transmission and HIV and syphilis co-infection (PR = 2.1; 95%CI: 1.21-3.74; P = 0.01) that persisted in the adjusted analysis. CONCLUSION: A profile of increased vulnerability was identified among pregnant women with HIV and syphilis coinfection. A positive impact of the treatment to reduce congenital syphilis and eliminate vertical transmission of HIV depends on enhanced access to qualified health care.

First and second COVID-19 waves in Brazil: A cross-sectional study of patients' characteristics related to hospitalization and in-hospital mortality.

BACKGROUND: Background The second wave of the COVID-19 pandemic was more aggressive in Brazil compared to other countries around the globe. Considering the Brazilian peculiarities, we analyze the in-hospital mortality concerning socio-epidemiological characteristics of patients and the health system of all states during the first and second waves of COVID-19. METHODS: We performed a cross-sectional study of hospitalized patients with positive RT-PCR for SARS-CoV-2 in Brazil. Data was obtained from the Influenza Epidemiological Surveillance Information System (SIVEP-Gripe) and comprised the period from February 25, 2020, to April 30, 2021, separated in two waves on November 5, 2020. We performed a descriptive study of patients analyzing socio-demographic characteristics, symptoms, comorbidities, and risk factors stratified by age. In addition, we analyzed in-hospital and intensive care unit (ICU) mortality in both waves and how it varies in each Brazilian state. FINDINGS: Between February 25, 2020 and April 30, 2021, 678 235 patients were admitted with a positive RT-PCR for SARS-CoV-2, with 325 903 and 352 332 patients for the first and second wave, respectively. The mean age of patients was 59 · 65 (IQR 48 · 0 - 72 · 0). In total, 379 817 (56 · 00%) patients had a risk factor or comorbidity. In-hospital mortality increased from 34 · 81% in the first to 39 · 30% in the second wave. In the second wave, there were more ICU admissions, use of non-invasive and invasive ventilation, and increased mortality for younger age groups. The southern and southeastern regions of Brazil had the highest hospitalization rates per 100 000 inhabitants. However, the in-hospital mortality rate was higher in the northern and northeastern states of the country. Racial differences were observed in clinical outcomes, with White being the most prevalent hospitalized population, but with Blacks/Browns (Pardos) having higher mortality rates. Younger age groups had more considerable differences in mortality as compared to groups with and without comorbidities in both waves. INTERPRETATION: We observed a more considerable burden on the Brazilian hospital system throughout the second wave. Furthermore, the north and northeast of Brazil, which present lower Human Development Indexes, concentrated the worst in-hospital mortality rates. The highest mortality rates are also shown among vulnerable social groups. Finally, we believe that the results can help to understand the behavior of the COVID-19 pandemic in Brazil, helping to define public policies, allocate resources, and improve strategies for vaccination of priority groups. FUNDING: Coordinating Agency for Advanced Training of Graduate Personnel (CAPES) (C.F. 001), and National Council for Scientific and Technological Development (CNPq) (No. 309537/2020-7).

Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.

In Southernmost Brazil HIV-1 subtypes B, C, and CRF31_BC co-circulates and, since 1996 with the implementation of free access to highly active antiretroviral treatment (HAART), this epidemic is under a quite characteristic selective pressure. The profile of mutations and polymorphisms in the protease (PR) and reverse transcriptase (RT) genes of HIV-1 from untreated patients living in Porto Alegre, Southernmost Brazil were evaluated in order to identify the subtypes and circulating drug resistant genotypes. Blood samples from 99 HIV-1 positive drugs-naïve patients were collected from 2006 to 2007 in Porto Alegre, Brazil. HIV PR and RT genes were amplified, sequenced, and subtyped. The HIV-1 genotyping was performed by partial sequence analysis of the pol in the HIV Drug Resistance Database of Stanford University. Phylogenetic analyses allowed to classify the HIV samples according to their subtypes: B (26.2%), C (39.4%), F (1.1%), CRF31_CB (19.2%), and URF (14.1%). Eight (8.1%) samples showed primary resistance mutations according to the Calibrated Population Resistance tool based in the 2009 Surveillance Drug Resistance Mutation list. Two samples presented resistance mutations to PI, three NRTI and three NNRTI. There was no significant association between presence of resistant genotypes and subtypes, but resistance mutations seem to be less frequent in the subtype C. In addition, this study describes for the first time the mutational profile of CRF31_BC to PI, NRTI, and NNRTI. Genetic analyses of HIV-1 from naïve patients are a promising and important method for surveillance of HIV infection.

Spatial and spatio-temporal distribution of women living with HIV mortality in Porto Alegre, Brazil, from 2007 to 2017.

OBJETIVE: To present some factors related to the mortality rates of WLHIV in the city of Porto Alegre-RS. METHODS: This is a spatial and spatio-temporal analysis of ecological data about all women monitored by the health care services for the vertical transmission (VT) of HIV, between 2007 and 2017, residing in the city that died during the period. The units of analysis were the 17 sanitary districts of the city. The dependent variable was the mortality rate. The independent territorial variables were the indicators of vulnerability to poverty, women householder proportion, lack of infrastructure, HDI, and GINI index. Still, the individual data collected were: age, race/color, level of education, and period since the HIV diagnosis. The analyses used SPSS 20.0, and QGIS 218.15. RESULTS: Regions with higher vulnerability to poverty and precarious local infrastructure registered higher WLHIV mortality rates, especially black/"pardo" women in fertile age with low education. The regions with most women householders presented a risk of mortality seven times higher. The population with vulnerability to poverty presented the same result. CONCLUSIONS: Regions with critical indicators of vulnerability presented higher mortality rates of WLHIV, which demonstrates social inequalities' impact for these women.

Social inequalities in the use of contraceptives in adult women from Southern Brazil.

OBJECTIVE: To describe the contraceptive methods used by adult women and the associated socioeconomic and demographic factors. METHODS: Population-based cross-sectional study with 20 to 49-year-old women from São Leopoldo, state of Rio Grande do Sul, in 2015. Three outcomes were considered to analyze the association with demographic and socioeconomic characteristics: use of oral contraceptive pills, tubal ligation and male condom. The crude prevalence ratios, stratified by age, and 95% confidence intervals (95%CI) were obtained using Poisson regression, taking the experimental error into account. RESULTS: A total of 736 women, aged from 20 to 49 years old, were evaluated. The prevalence of the use of oral contraceptive pills, tubal ligation and male condom were respectively 31.8% (95%CI 28.4-35.3), 11.1% (95%CI 9.0-13.6) and 10.9% (95%CI 8.7-13.3). In addition, 10.5% (n = 77) of the women reported making combined use of oral contraceptive pills and condom. In the stratified analysis, younger women with lower education level and from lower social classes reported less use of oral contraceptive pills. Tubal ligation was more prevalent among the lower social classes, but only in the age group from 30 to 39 years old. No differences were found in relation to male condom. CONCLUSIONS: The results indicated that differences persist in relation to contraception, which can be associated with both the difficulties of access to these inputs and the frailty of actions in reproductive health to achieve the needs and preferences of women who are more socially vulnerable.

Pharmacotherapeutic profile of users and expenditure on high-cost drugs in São Leopoldo, Rio Grande do Sul State, Brazil, 2014. / Perfil farmacoterapêutico dos usuários e gasto com medicamentos de alto custo em São Leopoldo, Rio Grande do Sul, Brasil, 2014.

OBJECTIVE: to describe the pharmacotherapeutic profile of users of the Specialized Program for Pharmaceutical Assistance, and to measure the expenditure on the most prevalent and the most expensive medications. METHODS: descriptive study conducted in São Leopoldo-RS, Brazil, with secondary data regarding information about requests accepted in 2014, through administrative proceedings; delivery notes of the State Health Department/RS were used to assess the costs. RESULTS: 1,528 users were included in the study, mostly women (56.7%), and the average age was 52 years (standard deviation=17.9); the most frequent diagnoses were allergic asthma (17.1%), chronic kidney disease (11.5%) and rheumatoid arthritis (8.4%); the most prevalent drug was budesonide+formoterol fumarate (18.3%); among the most prevalent drugs, the highest total monthly expense was with epoetin alfa (BRL37,922.34) and among the most expensive drugs, infliximab (BRL72,503.28). CONCLUSION: the data show the importance of the Specialized Program for Pharmaceutical Assistance in the high-cost treatment of highly prevalent.

Spatial and spatio-temporal distribution of women living with HIV mortality in Porto Alegre, Brazil, from 2007 to 2017 / Distribuição espacial e espaço temporal de óbitos de mulheres vivendo com HIV em Porto Alegre de 2007 a 2017

ABSTRACT OBJETIVE: To present some factors related to the mortality rates of WLHIV in the city of Porto Alegre-RS. METHODS: This is a spatial and spatio-temporal analysis of ecological data about all women monitored by the health care services for the vertical transmission (VT) of HIV, between 2007 and 2017, residing in the city that died during the period. The units of analysis were the 17 sanitary districts of the city. The dependent variable was the mortality rate. The independent territorial variables were the indicators of vulnerability to poverty, women householder proportion, lack of infrastructure, HDI, and GINI index. Still, the individual data collected were: age, race/color, level of education, and period since the HIV diagnosis. The analyses used SPSS 20.0, and QGIS 218.15. RESULTS: Regions with higher vulnerability to poverty and precarious local infrastructure registered higher WLHIV mortality rates, especially black/"pardo" women in fertile age with low education. The regions with most women householders presented a risk of mortality seven times higher. The population with vulnerability to poverty presented the same result. CONCLUSIONS: Regions with critical indicators of vulnerability presented higher mortality rates of WLHIV, which demonstrates social inequalities' impact for these women.

RESUMO OBJETIVO: Apresentar fatores associados à taxa de óbitos de mulheres vivendo com HIV (MVHIV) na cidade de Porto Alegre-RS. MÉTODOS: Estudo ecológico de análise espacial e espaço temporal incluindo todas as mulheres acompanhadas nos serviços de atenção à transmissão vertical (TV) do HIV, entre 2007 e 2017, residentes no município e que faleceram nesse período. As unidades de análise foram os 17 distritos sanitários do município. A variável dependente foi a taxa de óbito e as independentes territoriais foram os indicadores de vulnerabilidade à pobreza, proporção de mulheres chefe de família, escassez de infraestrutura, IDH e o índice de GINI, já as advindas da informação individual foram: idade, raça/cor, escolaridade, tempo de diagnóstico HIV. As análises utilizaram o SPSS 20.0 e o QGIS 218.15. RESULTADOS: Taxas mais elevadas de óbito de MVHIV foram registradas nas regiões com maior vulnerabilidade à pobreza e precariedade na infraestrutura local, associadas ao desfecho em mulheres em idade fértil, pretas/pardas e de baixa escolaridade. Nas regiões com altas taxas de mulheres que chefiam a família, a prevalência de óbito foi sete vezes maior, mesmo resultado obtido com a proporção populacional de vulnerabilidade à pobreza. CONCLUSÕES: As regiões que apresentam indicadores de vulnerabilidade críticos resultaram em taxas mais elevadas de óbito em MVHIV, revelando o impacto das desigualdades sociais em saúde para a morte dessas mulheres.

Strategies to prevent HIV transmission to serodiscordant couples.

INTRODUCTION: The use antiretroviral reduces the sexual transmission of HIV, expanding interventions for serodiscordant couples. OBJECTIVE: This article aims to review the use of antiretroviral and other prevention interventions among serodiscordant couples and to analyze its use in Brazil. METHODS: A retrospective review was performed through the MEDLINE database and bases included in the Biblioteca Virtual em Saúde. RESULTS: The articles recovered exhibit four main strategies: (1) condom; (2) reduction of risks in sexual practices; (3) use of antiretrovirals, particularly early initiation of antiretroviral therapy (TASP) and pre-exposure prophylaxis (PrEP); (4) risk reduction in reproduction. DISCUSSION: TASP is highly effective in reducing sexual transmission, PrEP was tested in serodiscordant couples and both reduce the sexual transmission risk in different sexual practices, enabling individualized prevention strategies. CONCLUSIONS: When used in combination, antiretrovirals and sexual practices with condoms offer greater efficacy than any single strategy. The combined use of new and old strategies allows us to build a prevention policy for all.

[Cost-effectiveness in health in Brazil: a systematic review]. / Estudos de custo-efetividade em saúde no Brasil: uma revisão sistemática.

A systematic review was performed with the aim of describing the landscape and evolution of cost-effectiveness studies in health in Brazil. The search for articles on cost-effectiveness was performed in the main electronic health databases. The review identified 83 cost-effectiveness studies conducted nationwide. Between the years 1990-2005 there were few studies published on cost-effectiveness, though between 2006 and 2014 there was a significant increase in the number of publications. As for the themes and objectives of the studies, the chronic degenerative diseases and infectious/contagious diseases reflect the epidemiological diversity of Brazil. A predominance of studies on health intervention/treatment was identified. Thus, this review reveals a compatible Brazilian epidemiological reality scenario, indicating a need to increase research and investment of funds in the area of preventive health.

Social inequalities in the use of contraceptives in adult women from Southern Brazil / Desigualdades sociais no uso de contraceptivos em mulheres adultas no Sul do Brasil

ABSTRACT OBJECTIVE: To describe the contraceptive methods used by adult women and the associated socioeconomic and demographic factors. METHODS: Population-based cross-sectional study with 20 to 49-year-old women from São Leopoldo, state of Rio Grande do Sul, in 2015. Three outcomes were considered to analyze the association with demographic and socioeconomic characteristics: use of oral contraceptive pills, tubal ligation and male condom. The crude prevalence ratios, stratified by age, and 95% confidence intervals (95%CI) were obtained using Poisson regression, taking the experimental error into account. RESULTS: A total of 736 women, aged from 20 to 49 years old, were evaluated. The prevalence of the use of oral contraceptive pills, tubal ligation and male condom were respectively 31.8% (95%CI 28.4-35.3), 11.1% (95%CI 9.0-13.6) and 10.9% (95%CI 8.7-13.3). In addition, 10.5% (n = 77) of the women reported making combined use of oral contraceptive pills and condom. In the stratified analysis, younger women with lower education level and from lower social classes reported less use of oral contraceptive pills. Tubal ligation was more prevalent among the lower social classes, but only in the age group from 30 to 39 years old. No differences were found in relation to male condom. CONCLUSIONS: The results indicated that differences persist in relation to contraception, which can be associated with both the difficulties of access to these inputs and the frailty of actions in reproductive health to achieve the needs and preferences of women who are more socially vulnerable.

RESUMO OBJETIVO: Descrever os métodos contraceptivos utilizados e fatores demográficos e socioeconômicos associados em mulheres adultas. MÉTODOS: Estudo transversal de base populacional com mulheres de 20 a 49 anos de São Leopoldo, RS, em 2015. Foram considerados três desfechos para analisar a associação com características demográficas e socioeconômicas: uso de anticoncepcional oral, ligadura tubária e uso de preservativo masculino. Foram obtidas razões de prevalências, brutas e estratificadas por idade, e intervalos de confiança de 95% (IC95%) por meio de regressão de Poisson, levando em conta o erro de delineamento. RESULTADOS: Foram avaliadas 736 mulheres com idades entre 20 e 49 anos. A prevalência de uso de anticoncepcional oral, de ligadura tubária e de uso de preservativo masculino foram, respectivamente, 31,8% (IC95% 28,4-35,3), 11,1% (IC95% 9,0-13,6) e 10,9% (IC95% 8,7-13,3). Além disso, 10,5% (n = 77) das mulheres relataram fazer uso combinado de anticoncepcional oral e preservativo masculino. Na análise estratificada, as mulheres mais jovens, de menor escolaridade e classe econômica mais baixa relataram menor uso de anticoncepcional oral. Já a ligadura tubária foi mais prevalente entre as de classe econômica mais baixa, mas apenas na faixa etária de 30 a 39 anos. Não foram encontradas diferenças quanto ao preservativo masculino. CONCLUSÕES: Os resultados indicaram que ainda persistem diferenças quanto à contracepção, o que pode se relacionar tanto a dificuldades no acesso a esses insumos como a fragilidades das ações em saúde reprodutiva para atingir as necessidades e preferências das mulheres em maior vulnerabilidade social.

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.

BACKGROUND: Concurrent treatment of HIV and tuberculosis is complicated by drug interactions. We explored the safety and efficacy of raltegravir as an alternative to efavirenz for patients co-infected with HIV and tuberculosis. METHODS: We did a multicentre, phase 2, non-comparative, open-label, randomised trial at eight sites in Brazil and France. Using a computer-generated randomisation sequence, we randomly allocated antiretroviral-naive adult patients with HIV-1 and tuberculosis (aged ≥18 years with a plasma HIV RNA concentration of >1000 copies per mL) to receive raltegravir 400 mg twice a day, raltegravir 800 mg twice daily, or efavirenz 600 mg once daily plus tenofovir and lamivudine (1:1:1; stratified by country). Patients began study treatment after the start of tuberculosis treatment. The primary endpoint was virological suppression at 24 weeks (HIV RNA <50 copies per mL) in all patients who received at least one dose of study drug (modified intention-to-treat analysis). We recorded death, study drug discontinuation, and loss to follow-up as failures to achieve the primary endpoint. We assessed safety in all patients who received study drugs. This study is registered in ClinicalTrials.gov, number NCT00822315. FINDINGS: Between July 3, 2009, and June 6, 2011, we enrolled and randomly assigned treatment to 155 individuals; 153 (51 in each group) received at least one dose of the study drug and were included in the primary analysis. 133 patients (87%) completed follow-up at week 48. At week 24, virological suppression was achieved in 39 patients (76%, 95% CI 65-88) in the raltegravir 400 mg group, 40 patients (78%, 67-90) in the raltegravir 800 mg group, and 32 patients (63%, 49-76) in the efavirenz group. The adverse-event profile was much the same across the three groups. Three (6%) patients allocated to efavirenz and three (6%) patients allocated to raltegravir 800 mg twice daily discontinued the study drugs due to adverse events. Seven patients died during the study (one in the raltegravir 400 mg group, four in the raltegravir 800 mg group, and two in the efavirenz group): none of the deaths was deemed related to study treatment. INTERPRETATION: Raltegravir 400 mg twice daily might be an alternative to efavirenz for the treatment of patients co-infected with HIV and tuberculosis. FUNDING: French National Agency for Research on AIDS and Viral Hepatitis (ANRS), Brazilian National STD/AIDS Program-Ministry of Health.

The HIV-Brazil cohort study: design, methods and participant characteristics.

BACKGROUND: The HIV-Brazil Cohort Study was established to analyze the effectiveness of combination antiretroviral therapy (cART) and the impact of this treatment on morbidity, quality of life (QOL) and mortality. The study design, patients' profiles and characteristics of cART initiation between 2003 and 2010 were described. METHODOLOGY/PRINCIPAL FINDINGS: Since 2003, the HIV-Brazil Cohort has been following HIV-infected adults receiving cART at 26 public health care facilities, using routine clinical care data and self-reported QOL questionnaires. When not otherwise available, data are obtained from national information systems. The main outcomes of interest are diseases related or unrelated to HIV; suppression of viral replication; adverse events; virological, clinical and immunological failures; changes in the cART; and mortality. For the 5,061 patients who started cART between 2003 and 2010, the median follow-up time was 4.1 years (IQR 2.2-5.9 years) with an 83.4% retention rate. Patient profiles were characterized by a predominance of men (male/female ratio 1.7∶1), with a mean age of 36.9 years (SD 9.9 years); 55.2% had been infected with HIV via heterosexual contact. The majority of patients (53.4%) initiated cART with a CD4+ T-cell count ≤200 cells/mm3. The medications most often used in the various treatment regimens were efavirenz (59.7%) and lopinavir/ritonavir (18.2%). The proportion of individuals achieving viral suppression within the first 12 months of cART use was 77.4% (95% CI 76.1-78.6). Nearly half (45.4%) of the patients presented HIV-related clinical manifestations after starting cART, and the AIDS mortality rate was 13.9 per 1,000 person-years. CONCLUSIONS/SIGNIFICANCE: Results from cART use in the daily practice of health services remain relatively unknown in low- and middle-income countries, and studies with the characteristics of the HIV-Brazil Cohort contribute to minimizing these shortcomings, given its scope and patient profile, which is similar to that of the AIDS epidemic in the country.

Perfil farmacoterapêutico dos usuários e gasto com medicamentos de alto custo em São Leopoldo, Rio Grande do Sul, Brasil, 2014 / Perfil farmacoterapéutico de los usuarios y gasto en medicamentos de alto costo en São Leopoldo, Rio Grande do Sul, Brasil, 2014 / Pharmacotherapeutic profile of users and expenditure on high-cost drugs in São Leopoldo, Rio Grande do Sul State, Brazil, 2014

OBJETIVO: descrever o perfil farmacoterapêutico dos usuários do Componente Especializado da Assistência Farmacêutica (CEAF) e mensurar os gastos com os medicamentos mais prevalentes e os mais onerosos. MÉTODOS: estudo descritivo, realizado no município de São Leopoldo-RS, Brasil; utilizaram-se dados secundários sobre solicitações de medicamentos deferidas em 2014 via processo administrativo; para avaliar os custos, foram consultadas as guias de remessa da Secretaria de Estado da Saúde/RS. RESULTADOS: foram incluídos 1.528 usuários, sobretudo mulheres (56,7%), e idade média de 52 anos (desvio-padrão=17,9); os diagnósticos mais frequentes foram asma alérgica (17,1%), doença renal crônica (11,5%) e artrite reumatoide (8,4%); o medicamento mais prevalente foi o fumarato de formoterol+budesonida (18,3%); o maior gasto total mensal entre os medicamentos mais prevalentes foi com alfaepoetina (R$37.922,34), e entre os mais onerosos, com infliximab (R$72.503,28). CONCLUSÃO: os dados apontam para a importância do CEAF no tratamento de alto custo de morbidades com elevada prevalência.

OBJETIVO: describir el perfil farmacoterapéutico de usuarios del Programa de Asistencia Farmacéutica Especializada (CEAF), y medir los costos de los medicamentos más comunes y más costosos. MÉTODOS: estudio descriptivo realizado en São Leopoldo/RS, con datos secundarios sobre solicitudes de drogas diferidas en 2014 a través de procesos administrativos; para evaluar el costo, utilizamos las entregas de Secretaría Estatal de Salud/RS. RESULTADOS: se incluyeron 1.528 usuarios, la mayoría mujeres (56,7%), edad media 52 años (desviación estándar=17,9); los diagnósticos más frecuentes fueron asma alérgica (17,1%), enfermedad renal crónica (11,5%) y artritis reumatoide (8,4%); la droga más frecuente fue budesónida+formoterol fumarato (18,3%); el mayor gasto total mensual de los fármacos más prevalentes fue con alfaepoetina (R$37.922,34) y entre los más caros, con infliximab (R$72.503,28). CONCLUSIÓN: los datos señalan la importancia de este componente en el tratamiento de alto costo de morbilidad con altas prevalencias.

OBJECTIVE: to describe the pharmacotherapeutic profile of users of the Specialized Program for Pharmaceutical Assistance, and to measure the expenditure on the most prevalent and the most expensive medications. METHODS: descriptive study conducted in São Leopoldo-RS, Brazil, with secondary data regarding information about requests accepted in 2014, through administrative proceedings; delivery notes of the State Health Department/RS were used to assess the costs. RESULTS: 1,528 users were included in the study, mostly women (56.7%), and the average age was 52 years (standard deviation=17.9); the most frequent diagnoses were allergic asthma (17.1%), chronic kidney disease (11.5%) and rheumatoid arthritis (8.4%); the most prevalent drug was budesonide+formoterol fumarate (18.3%); among the most prevalent drugs, the highest total monthly expense was with epoetin alfa (BRL37,922.34) and among the most expensive drugs, infliximab (BRL72,503.28). CONCLUSION: the data show the importance of the Specialized Program for Pharmaceutical Assistance in the high-cost treatment of highly prevalent.

Coinfecção HIV/sífilis na gestação e transmissão vertical do HIV: um estudo a partir de dados da vigilância epidemiológica / HIV and syphilis coinfection in pregnancy and vertical HIV transmission: a study based on epidemiological surveillance data

Objetivo. Estimar a taxa de coinfecção do HIV/sífilis nas gestantes de Porto Alegre, estado do Rio Grande do Sul, e sua associação com a transmissão vertical do HIV e variáveis socioeconômicas. Método. Neste estudo transversal retrospectivo analítico, foram utilizados dados do sistema de vigilância epidemiológica de gestantes portadoras do HIV e crianças expostas e dados da sífilis na gestação e da sífilis congênita no período de 2010 a 2013. Resultados. A população do estudo incluiu 1 500 gestantes positivas para HIV com partos no período de 2010 a 2013. Dessas, 155 (10,3%) também eram infectadas por sífilis, correspondendo a uma taxa de coinfecção HIV/sífilis de 10,2% (± 1,5%). Foi encontrada menor escolaridade no grupo de gestantes coinfectadas, bem como maior prevalência de mulheres negras e maior exposição ao HIV relacionada ao uso de drogas pelo parceiro e pela gestante. Gestantes com coinfecção HIV/sífilis tiveram diagnóstico do HIV em momentos mais tardios, como no parto, além de maior prevalência de não realização de pré-natal (44%). Na análise bruta foi identificada associação da transmissão vertical do HIV com a presença de coinfecção HIV/sífilis (razão de prevalência = 2,1; IC95%: 1,21 a 3,74; P = 0,01), a qual se manteve na análise ajustada. Conclusão. Um perfil de maior vulnerabilidade foi evidenciado no grupo de gestantes coinfectadas por HIV/sífilis, enfatizando a importância de melhorar o acesso a atendimento qualificado à saúde para impacto positivo do tratamento na redução da sífilis congênita e na eliminação da transmissão vertical do HIV.

Objective. To estimate the rate of HIV and syphilis coinfection among pregnant women living in Porto Alegre, Brazil, as well as the association of coinfection with vertical HIV transmission and socioeconomic variables. Method. This analytical retrospective cross-sectional study employed data from the regular epidemiological surveillance system for the period from 2010 to 2013. Data were obtained regarding pregnant women with HIV and exposed children, syphilis in pregnancy, and congenital syphilis. Results. The study population included 1 500 HIV-positive women with deliveries from 2010 to 2013. Of these, 155 (10.3%) were also infected with syphilis, corresponding to an HIV and syphilis coinfection rate of 10.2% (± 1.5%). The coinfected group had lower education levels, higher prevalence of black women, and greater HIV exposure related to drug use by the woman or a partner. Coinfected women had more delayed HIV diagnosis (for example, during childbirth) and greater prevalence of lacking prenatal care (44%). Crude analysis showed an association between vertical HIV transmission and HIV and syphilis co-infection (PR = 2.1; 95%CI: 1.21-3.74; P = 0.01) that persisted in the adjusted analysis. Conclusion. A profile of increased vulnerability was identified among pregnant women with HIV and syphilis coinfection. A positive impact of the treatment to reduce congenital syphilis and eliminate vertical transmission of HIV depends on enhanced access to qualified health care.

Coinfecção HIV/sífilis na gestação e transmissão vertical do HIV: um estudo a partir de dados da vigilância epidemiológica / HIV and syphilis coinfection in pregnancy and vertical HIV transmission: a study based on epidemiological surveillance data

RESUMO Objetivo Estimar a taxa de coinfecção do HIV/sífilis nas gestantes de Porto Alegre, estado do Rio Grande do Sul, e sua associação com a transmissão vertical do HIV e variáveis socioeconômicas. Método Neste estudo transversal retrospectivo analítico, foram utilizados dados do sistema de vigilância epidemiológica de gestantes portadoras do HIV e crianças expostas e dados da sífilis na gestação e da sífilis congênita no período de 2010 a 2013. Resultados A população do estudo incluiu 1 500 gestantes positivas para HIV com partos no período de 2010 a 2013. Dessas, 155 (10,3%) também eram infectadas por sífilis, correspondendo a uma taxa de coinfecção HIV/sífilis de 10,2% (± 1,5%). Foi encontrada menor escolaridade no grupo de gestantes coinfectadas, bem como maior prevalência de mulheres negras e maior exposição ao HIV relacionada ao uso de drogas pelo parceiro e pela gestante. Gestantes com coinfecção HIV/sífilis tiveram diagnóstico do HIV em momentos mais tardios, como no parto, além de maior prevalência de não realização de pré-natal (44%). Na análise bruta foi identificada associação da transmissão vertical do HIV com a presença de coinfecção HIV/sífilis (razão de prevalência = 2,1; IC95%: 1,21 a 3,74; P = 0,01), a qual se manteve na análise ajustada. Conclusão Um perfil de maior vulnerabilidade foi evidenciado no grupo de gestantes coinfectadas por HIV/sífilis, enfatizando a importância de melhorar o acesso a atendimento qualificado à saúde para impacto positivo do tratamento na redução da sífilis congênita e na eliminação da transmissão vertical do HIV.

ABSTRACT Objective To estimate the rate of HIV and syphilis coinfection among pregnant women living in Porto Alegre, Brazil, as well as the association of coinfection with vertical HIV transmission and socioeconomic variables. Method This analytical retrospective cross-sectional study employed data from the regular epidemiological surveillance system for the period from 2010 to 2013. Data were obtained regarding pregnant women with HIV and exposed children, syphilis in pregnancy, and congenital syphilis. Results The study population included 1 500 HIV-positive women with deliveries from 2010 to 2013. Of these, 155 (10.3%) were also infected with syphilis, corresponding to an HIV and syphilis coinfection rate of 10.2% (± 1.5%). The coinfected group had lower education levels, higher prevalence of black women, and greater HIV exposure related to drug use by the woman or a partner. Coinfected women had more delayed HIV diagnosis (for example, during childbirth) and greater prevalence of lacking prenatal care (44%). Crude analysis showed an association between vertical HIV transmission and HIV and syphilis co-infection (PR = 2.1; 95%CI: 1.21-3.74; P = 0.01) that persisted in the adjusted analysis. Conclusion A profile of increased vulnerability was identified among pregnant women with HIV and syphilis coinfection. A positive impact of the treatment to reduce congenital syphilis and eliminate vertical transmission of HIV depends on enhanced access to qualified health care.